Search research articles
Contact Us
Filters
Showing results (81-90 of 239) with videos related to
Page
of 24
Sort By:
British Journal of Pharmacology
|
December 16, 2022
Combined targeting of fatty acid amide hydrolase and melatonin receptors promotes neuroprotection and stimulates inflammation resolution in rats
Mariarosaria Cammarota, Francesca Ferlenghi, Federica Vacondio, et al.
Neurobiology of Disease
|
May 3, 2006
Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease
Alessia Tarditi, Alessandra Camurri, Katia Varani, et al.
Frontiers in Pharmacology
|
April 8, 2021
An Open Question: Is the A<sub>2A</sub> Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?
Stefania Merighi, Tino Emanuele Poloni, Lucia Pelloni, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 25, 2016
Repeated Dosing with NCX1404, a Nitric Oxide-Donating Pregabalin, Re-establishes Normal Nociceptive Responses in Mice with Streptozotocin-Induced Painful Diabetic Neuropathy
Katia Varani, Fabrizio Vincenzi, Martina Targa, et al.
Journal of Cellular Physiology
|
August 9, 2017
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis
Matilde Tschon, Francesca Veronesi, Deyanira Contartese, et al.
Journal of Medicinal Chemistry
|
January 5, 2002
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility
Pier Giovanni Baraldi, Barbara Cacciari, Romeo Romagnoli, et al.
Molecular Diagnosis & Therapy
|
March 11, 2026
Colorectal Cancer: A Landscape of New Potential Radiopharmaceuticals
Veronica Serena Cabitza, Pier Cesare Capponi, Irene Brusa, et al.
Journal of Cellular Physiology
|
September 18, 2016
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells
Fabrizio Vincenzi, Annalisa Ravani, Silvia Pasquini, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 18, 2013
A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients
Fabrizio Vincenzi, Carmen Corciulo, Martina Targa, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A<sub>2A</sub> Adenosine Receptor Inverse Agonists with Antinociceptive Activity
Flavia Varano, Daniela Catarzi, Fabrizio Vincenzi, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 239) with videos related to
Sort By:
Page
of 24
British Journal of Pharmacology
|
December 16, 2022
Combined targeting of fatty acid amide hydrolase and melatonin receptors promotes neuroprotection and stimulates inflammation resolution in rats
Mariarosaria Cammarota, Francesca Ferlenghi, Federica Vacondio, et al.
Neurobiology of Disease
|
May 3, 2006
Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease
Alessia Tarditi, Alessandra Camurri, Katia Varani, et al.
Frontiers in Pharmacology
|
April 8, 2021
An Open Question: Is the A<sub>2A</sub> Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?
Stefania Merighi, Tino Emanuele Poloni, Lucia Pelloni, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 25, 2016
Repeated Dosing with NCX1404, a Nitric Oxide-Donating Pregabalin, Re-establishes Normal Nociceptive Responses in Mice with Streptozotocin-Induced Painful Diabetic Neuropathy
Katia Varani, Fabrizio Vincenzi, Martina Targa, et al.
Journal of Cellular Physiology
|
August 9, 2017
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis
Matilde Tschon, Francesca Veronesi, Deyanira Contartese, et al.
Journal of Medicinal Chemistry
|
January 5, 2002
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility
Pier Giovanni Baraldi, Barbara Cacciari, Romeo Romagnoli, et al.
Molecular Diagnosis & Therapy
|
March 11, 2026
Colorectal Cancer: A Landscape of New Potential Radiopharmaceuticals
Veronica Serena Cabitza, Pier Cesare Capponi, Irene Brusa, et al.
Journal of Cellular Physiology
|
September 18, 2016
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells
Fabrizio Vincenzi, Annalisa Ravani, Silvia Pasquini, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 18, 2013
A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients
Fabrizio Vincenzi, Carmen Corciulo, Martina Targa, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A<sub>2A</sub> Adenosine Receptor Inverse Agonists with Antinociceptive Activity
Flavia Varano, Daniela Catarzi, Fabrizio Vincenzi, et al.
Page
of 24